In March 2025, the company announced new strategies for your immediate-to-purchaser featuring of its Wegovy weight loss drug. The company set up a new pharmacy, referred to as NovoCare, which might charge consumers $499 monthly for entry to the drug, lower than fifty percent the expense of the drug via other pharmaceutical distribution networks.[53